InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by AGARWAL SUNIL, Directeur du Développement et Directeur Marketing. Officer active across 3 companies, notably Sana Biotechnology, Inc.. In total, 6 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €2.6m. History available since 15 September 2021. The latest transaction was disclosed on 29 May 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations6 total
5,899 shares0Common StockSEC:0001655759-24-000084:0
8,242 shares0Common StockSEC:0001655759-23-000059:0
58,373 shares@ US$26.06950.15% mcap50.0% of flowCommon StockSEC:0001562180-21-005999:0
58,373 shares@ US$26.069550.0% of flowCommon StockSEC:0001562180-21-005999
456 sharesCommon StockSEC:0001562180-16-001371:0
585 sharesCommon StockSEC:0001562180-16-001371:1
6 of 6 declarations
About AGARWAL SUNIL
Sunil Agarwal is the Executive Vice President, Head of Development and Chief Marketing Officer of Sana Biotechnology, Inc. He oversees the company's development and marketing strategies, aiming to strengthen its position in the biotechnology market.
